Markets

Home | Market | Company Info | Balance Sheet

Get Quotes

Market Menu

BALANCE SHEET-Vanta Bioscience Ltd.

You can view the balance sheet for the last 5 years.

BSE

May 16

73.50 -1.70 ( -2.26%)

Volume 1500

Prev. Close 75.20

Open Price 71.44

Today's Low / High

71.44

73.50

Bid Price(Qty.) 0.00 (0)

Open Pr.(Qty.) 0.00 (0)

52 Wk Low / High

37.00

101.64

Vanta Bioscience Ltd.is not traded in NSE

ISIN No	INE695X01011	Market Cap. ( )	46.39	P/BV	2.65	Book Value ( )	27.75
BSE Code	540729	52 Week High/Low ( )	102/37	FV/ML	10/750	P/E(X)	0.00
NSE Code	-	Book Closure		EPS ( )	0.00	Div Yield (%)	0.00

( )

Particulars	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00
No. of Equity Shares (in Lacs)	63.12	63.12	63.12	63.12	63.12

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	6.31	6.31	6.31	6.31	6.31
Total Share Capital	6.31	6.31	6.31	6.31	6.31

Reserves and Surplus	11.20	17.70	17.61	17.16	15.94
Total Reserves and Surplus	11.20	17.70	17.61	17.16	15.94
Total Shareholders Funds	17.51	24.01	23.92	23.47	22.25
Minority Interest	1.41	5.34	2.31	0.99	0.98

NON-CURRENT LIABILITIES
Long Term Borrowings	47.07	37.00	27.84	13.65	12.17
Deferred Tax Liabilities [Net]	0.97	0.78	0.72	0.59	0.40
Total Non-Current Liabilities	48.03	37.78	28.56	14.24	12.57

CURRENT LIABILITIES
Short Term Borrowings	10.09	7.87	4.15	1.88	0.00
Trade Payables	4.22	2.46	0.47	0.49	0.46
Other Current Liabilities	3.43	3.91	10.16	7.42	2.62
Short Term Provisions	0.00	0.04	0.06	0.08	0.12
Total Current Liabilities	17.75	14.28	14.84	9.87	3.20

Total Capital And Liabilities	84.71	81.40	69.63	48.57	39.00

ASSETS
NON-CURRENT ASSETS
Tangible Assets	33.23	14.54	15.52	15.89	16.74
Intangible Assets	24.00	21.59	0.00	0.00	0.00
Capital Work-In-Progress	0.00	22.78	19.34	7.00	0.00
Intangible Assets Under Development	10.60	5.69	0.00	0.00	0.00
Other Assets	0.00	0.00	13.87	4.86	4.86
Fixed Assets	67.83	64.59	48.73	27.76	21.60
Other Non-Current Assets	1.64	2.32	0.97	0.97	0.35
Total Non-Current Assets	69.47	66.91	49.69	28.73	21.95


CURRENT ASSETS
Current Investments	0.00	0.00	0.00	0.00	1.95
Inventories	7.16	7.24	9.76	14.01	9.24
Trade Receivables	1.96	1.13	2.01	1.39	1.56
Cash And Cash Equivalents	0.10	0.22	2.65	0.20	3.27
Short Term Loans And Advances	5.38	5.18	4.87	3.92	0.91
OtherCurrentAssets	0.65	0.72	0.64	0.33	0.12
Total Current Assets	15.24	14.50	19.94	19.85	17.05

Total Assets	84.71	81.40	69.63	48.57	39.00

CURRENT INVESTMENTS
Current Investments Unquoted Book Value	0.00	0.00	0.00	0.00	1.95

Particulars	Mar 23
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	10.00
No. of Equity Shares (in Lacs)	63.12

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	6.31
Total Share Capital	6.31
Reserves and Surplus	11.20
Total Reserves and Surplus	11.20
Total Shareholders Funds	17.51
Minority Interest	1.41
NON-CURRENT LIABILITIES
Long Term Borrowings	47.07
Deferred Tax Liabilities [Net]	0.97
Total Non-Current Liabilities	48.03
CURRENT LIABILITIES
Short Term Borrowings	10.09
Trade Payables	4.22
Other Current Liabilities	3.43
Short Term Provisions	0.00
Total Current Liabilities	17.75
Total Capital And Liabilities	84.71
ASSETS
NON-CURRENT ASSETS
Tangible Assets	33.23
Intangible Assets	24.00
Capital Work-In-Progress	0.00
Intangible Assets Under Development	10.60
Other Assets	0.00
Fixed Assets	67.83
Other Non-Current Assets	1.64
Total Non-Current Assets	69.47
CURRENT ASSETS
Current Investments	0.00
Inventories	7.16
Trade Receivables	1.96
Cash And Cash Equivalents	0.10
Short Term Loans And Advances	5.38
OtherCurrentAssets	0.65
Total Current Assets	15.24
Total Assets	84.71
CURRENT INVESTMENTS
Current Investments Unquoted Book Value	0.00